Apollomics (APLM) Retained Earnings (2021 - 2025)

Apollomics (APLM) posted quarterly Retained Earnings of -$711.8 million for Q4 2025, down 1.56% year-on-year from -$723.0 million in Q4 2024, and little changed on a QoQ basis from -$713.4 million in Q2 2025.

Apollomics (APLM) Retained Earnings (2021 - 2025) Analysis & Trends

Apollomics (APLM) has reported Retained Earnings for 5 consecutive years, with -$711.8 million the latest figure, recorded in Q4 2025.

  • Quarterly Retained Earnings fell 1.56% year-over-year to -$711.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$711.8 million (down 1.56% YoY) and the FY2025 annual result came in at -$711.8 million, down 1.56% from the prior year.
  • Retained Earnings was little changed at -$711.8 million in Q4 2025 per APLM's latest filing, from -$713.4 million in the prior quarter.
  • Over the last five years, Retained Earnings for APLM reached as high as $36.4 million in Q2 2024 and fell as low as -$713.4 million in Q2 2025.
  • A 5-year average of -$255.2 million and a median of -$5.8 million in 2023 frame the typical range for Retained Earnings.
  • Annual changes were most pronounced in 2023 — Retained Earnings surged 39694.76% — and 2024, when it slumped 11983.16%.
  • Year by year, Retained Earnings stood at -$235.4 million in 2021, then soared by 106.04% to $14.2 million in 2022, then plunged by 140.76% to -$5.8 million in 2023, then sank by 11983.16% to -$700.8 million in 2024, then decreased by 1.56% to -$711.8 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods registered -$711.8 million, -$713.4 million, and -$700.8 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -527.87 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -27.89 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 12.91 Bn
4 NuCana 279.75 Bn 279.75 Bn - 115.82 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 11.90 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -622,000.00
10 Apollomics 2.66 Bn 2.66 Bn - -711.76 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -711.76 Mn
Jun 30, 2025 -713.36 Mn
Dec 31, 2024 -700.82 Mn
Jun 30, 2024 36.45 Mn
Dec 31, 2023 -5.80 Mn
Jun 30, 2023 19.31 Mn
Dec 31, 2022 14.23 Mn
Jun 30, 2022 48,529.00
Dec 31, 2021 -235.44 Mn